BRISBANE, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. announced today that it will present at the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference to be held on October 26, 2005 at The Palace Hotel in New York City.
Richard C. Williams, Cellegy’s Chairman and Interim CEO, is scheduled to speak on Wednesday, October 26, 2005 at 2:20 p.m. (Eastern).
Interested parties can access a live audio plus presentation slides webcast at www.cellegy.com. A replay of the presentation will be available for 14 days.
Cellegy Pharmaceuticals is a specialty biopharmaceutical company that develops and commercializes prescription drugs for the treatment of women’s health care conditions, including reduction in the transmission of HIV and sexual dysfunction, as well as gastrointestinal disorders.
Cellegy Pharmaceuticals, Inc.
CONTACT: Robert J. Caso, Vice President, Finance & CFO, +1-215-914-0900,or Richard C. Williams, Chairman and Interim CEO, +1-650-616-2200, both ofCellegy Pharmaceuticals, Inc.
Web site: http://www.cellegy.com/
